ClinicalTrials.gg
Sign In

Leukemia, Promyelocytic, Acute clinical trials

The registry lists 134 studies for Leukemia, Promyelocytic, Acute across more than 10 countries. 16 are recruiting or about to start. 82 of them are mainly about Leukemia, Promyelocytic, Acute (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Leukemia, Promyelocytic, Acute studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
76
Status unknown
19
Terminated
13
Recruiting
12
Active, not recruiting
4
Not yet recruiting
3

Phase

Phase 2
49
Phase 1
38
Phase 3
21
Phase 4
8

Where

United States
86
Italy
12
Germany
12
China
8
France
6
Canada
6

Who runs them

National Cancer Institute (NCI) (19) · Gruppo Italiano Malattie EMatologiche dell'Adulto (8) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (7) · Memorial Sloan Kettering Cancer Center (6) · Children's Oncology Group (6) · M.D. Anderson Cancer Center (5) · Case Comprehensive Cancer Center (4) · Alliance for Clinical Trials in Oncology (3)

What is being tested here

Drugs under test in Leukemia, Promyelocytic, Acute studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Arsenic Trioxide3418
Tretinoin2516
Gemtuzumab204
Etoposide103
Venetoclax112
Arsenic Trioxide Capsule Formulation ORH 2014102
Lisaftoclax111
Pexidartinib101
Realgar-Indigo naturalis Formulation101
Cytarabine028

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · Antimetabolites 20 · Alkylating agents 9 · HDAC inhibitors 5

Coming up

5phase 3 studies under way
5studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5, phase 3 first

Who these studies take

Of the 12 Leukemia, Promyelocytic, Acute studies recruiting now, 7 (58%) set no upper age limit and 5 (42%) stop at 75 or younger. 5 (42%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
105 (42%)5 (42%)
1812 (100%)12 (100%)
3011 (92%)11 (92%)
4010 (83%)10 (83%)
5010 (83%)10 (83%)
6510 (83%)10 (83%)
759 (75%)9 (75%)
857 (58%)7 (58%)

Across all 134 studies, recruiting or not: 34% stop at 75 or younger and 17% at 65; 47% take children; 1% are for women only and 0% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 134. Browse all 134 → or search them.